1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MINERALYS THERAPEUTICS INC
Mineralys Therapeutics Inc XNAS: MLYS

Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

Read More
26.55 -0.17 (-0.64%)
44.28% Fall from 52W High
322.7K
XNAS Volume

XNAS 06 Mar, 2026 10:42 AM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Mineralys Therapeutics Inc took place on 05 Mar 2026, for the purpose of Mineralys Therapeutics Inc Fourth Quarter Earnings Conference Call for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
7.0 / 100
Momentum Score
Technically Neutral
47.2 / 100
Analyst Price Target
No estimates available

3

S

10

W

4

O

1

T

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..